Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2870880 | 1.00 | CYP1A2 (0.52) | CYP1A2LMNATSHRCA2CA4 | |
| SCHEMBL1000520 | 0.89 | LMNA (0.50) | CYP1A2LMNATSHRCA2CA4 | |
| SCHEMBL10523794 | 0.88 | TSHR (0.42) | CYP1A2LMNATSHRALDH1A1HPGD | |
| SCHEMBL5436616 | 0.87 | LMNA (0.60) | LMNATSHRCA2CA4CA5A | |
| SCHEMBL132983 | 0.87 | LMNA (0.60) | LMNATSHRCA2CA4CA5A | |
| SCHEMBL5439069 | 0.87 | LMNA (0.60) | LMNATSHRCA2CA4CA5A | |
| Triphenylphosphine Oxide SCHEMBL3949 | 0.84 | CA2 (0.58) | LMNATSHRCA2CA4CA5A | |
| Triphenylphosphine Oxide SCHEMBL513223 | 0.84 | CA2 (0.58) | LMNATSHRCA2CA4CA5A | |
| SCHEMBL10524389 | 0.83 | NPSR1 (0.40) | CYP1A2LMNATSHRCA2CA4 | |
| SCHEMBL4774848 | 0.81 | LMNA (0.56) | LMNATSHRCA2CA4CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119591638-A | Heterocyclic compound, organic electroluminescent element comprising same and electronic device | 海宁奕诺炜特科技有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-115055207-B | Method for preparing aryl phosphine by reducing aryl phosphine oxide | 清华大学 | 2023-07-21 | — | — | CN | disclosed |
| CN-109535064-B | Compound, display panel and display device | 武汉天马微电子有限公司 | 2023-01-24 | — | — | CN | disclosed |
| CN-115055207-A | Method for preparing aryl phosphine by reducing aryl phosphine oxide | 清华大学 | 2022-09-16 | — | — | CN | disclosed |
| US-20190322623-A1 | COMPOUND, DISPLAY PANEL, AND DISPLAY APPARATUS | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2019-10-24 | — | — | US | disclosed |
| US-4806691-A | Process for the preparation of tertiary phosphine oxides | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190322623-A1 | COMPOUND, DISPLAY PANEL, AND DISPLAY APPARATUS | DRD2, GRIN2D, DRD1 | CYP1A2 1461/4885LMNA 1991/4885TSHR 3646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.